1. Patankar VC, Sangle JP, Shah HR, Dave M, Kamath RM. Neurological soft signs in children with attention deficit hyperactivity disorder. Indian J Psychiatry 2012;54:159-165. PMID:
22988324.
2. Shafer SQ, Shaffer D, O'Connor PA, Stokman CJ. Hard Thoughts on Neurological "Soft Signs". In: Rutter M, editor. Developmental Neuropsychiatry. New York: Guilford Press, 1983, p. 133-143.
3. Martins I, Lauterbach M, Slade P, Luis H, De Rouen T, Martin M, et al. A longitudinal study of neurological soft signs from late childhood into early adulthood. Dev Med Child Neurol 2008;50:602-607. PMID:
18754898.
4. Mostofsky SH, Newschaffer CJ, Denckla MB. Overflow movements predict impaired response inhibition in children with ADHD. Percept Mot Skills 2003;97:1315-1331. PMID:
15002876.
5. Pasini A, D'Agati E. Pathophysiology of NSS in ADHD. World J Biol Psychiatry 2009;10:495-502. PMID:
19337883.
6. Larson JC, Mostofsky SH, Goldberg MC, Cutting LE, Denckla MB, Mahone EM. Effects of gender and age on motor exam in typically developing children. Dev Neuropsychol 2007;32:543-562. PMID:
17650993.
7. Lerer RJ, Lerer MP. The effects of methylphenidate on the soft neurological signs of hyperactive children. Pediatrics 1976;57:521-525. PMID:
772581.
8. Touwen BC, Sporrel T. Soft signs and MBD. Dev Med Child Neurol 1979;21:528-530. PMID:
520701.
9. Henderson SE, Hall D. Concomitants of clumsiness in young schoolchildren. Dev Med Child Neurol 1982;24:448-460. PMID:
7117703.
10. Guy W. Physical and Neurological Examination for Soft Signs (PANESS). In: Guy W, editor. ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: National Institute of Mental Health, 1976, p. 383-393.
11. Denckla MB. Revised neurological examination for subtle signs (1985). Psychopharmacol Bull 1985;21:773-800. PMID:
4089106.
12. Largo RH, Fischer JE, Caflisch JA. Zurich Neuromotor Assessment. Zürich: AWE Verlag; 2002.
13. Ferrin M, Vance A. Examination of neurological subtle signs in ADHD as a clinical tool for the diagnosis and their relationship to spatial working memory. J Child Psychol Psychiatry 2012;53:390-400. PMID:
22141455.
14. Sangal RB, Owens J, Allen AJ, Sutton V, Schuh K, Kelsey D. Effects of atomoxetine and methylphenidate on sleep in children with ADHD. Sleep 2006;29:1573-1585. PMID:
17252888.
16. Senger EY, Hallum G. Methylphenidate in children with minimal brain dysfunction: effects on attention span, visual motor skills and behavior. Curr Ther Res Clin Exp 1974;16:635-641. PMID:
4211145.
17. Lerer RJ, Lerer MP, Artner J. The effects of methylphenidate on the handwriting of children with minimal brain dysfunction. J Pediatr 1977;91:127-132. PMID:
874649.
18. Tirosh E, Elhasid R, Kamah SC, Cohen A. Predictive value of placebo methylphenidate. Pediatr Neurol 1993;9:131-133. PMID:
8499043.
19. Peeples EE, Searls DT, Wellingham-Jones P. Attention-deficit hyperactivity disorder: a longitudinal case study of handwriting characteristics. Percept Mot Skills 1995;81:1243-1252. PMID:
8684920.
20. DuPaul GJ, Power TJ, Anastopoulos AD, Reid R. ADHD Rating Scale-IV: Checklists, Norms, and Clinical Interpretation. New York: Guilford Press; 1998.
21. Whalen CK, Henker B. Social impact of stimulant treatment for hyperactive children. J Learn Disabil 1991;24:231-241. PMID:
1875158.
22. Schachar RJ, Tannock R, Cunningham C, Corkum PV. Behavioral, situational, and temporal effects of treatment of ADHD with methylphenidate. J Am Acad Child Adolesc Psychiatry 1997;36:754-763. PMID:
9183129.
23. Musten LM, Firestone P, Pitserman S, Bennett S, Mercer J. Effects of methylphenidate on preschool children with ADHD: cognitive and behavioral functions. J Am Acad Child Adolesc Psychiatry 1997;36:1407-1415. PMID:
9334554.
24. Abikoff H, Hechtnab L, Klein RG, Weiss G, Fleiss K, Etcovitch J, et al. Symptomatic improvement in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. J Am Acad Child Adolesc Psychiatry 2004;43:802-811. PMID:
15213581.
25. Rubia K, Noorloos J, Smith A, Gunning B, Sergeant J. Motor timing deficits in community and clinical boys with hyperactive behavior: the effect of methylphenidate on motor timing. J Abnorm Child Psychol 2003;31:301-313. PMID:
12774863.
26. Hoshi E, Tanii J. Differential roles of neuronal activity in the supplementary and presupplementary motor areas: from information retrieval to motor planning and execution. J Neurophysiol 2004;92:3482-3499. PMID:
15269227.
27. Doya K. Complementary roles of basal ganglia and cerebellum in learning and motor control. Curr Opin Neurobiol 2000;10:732-739. PMID:
11240282.
28. Sakai K, Hikosaka O, Takino R, Miyauchi S, Nielsen M, Tamada T. What and when: parallel and convergent processing in motor control. J Neurosci 2000;20:2691-2700. PMID:
10729350.
29. Mostofsky SH, Newschaffer CJ, Denckla MB. Overflov movements predict impaired response inhibition in children with ADHD. Percept Mot Skills 2003;97:1315-1331. PMID:
15002876.
30. Newcorn JH, Kratochvil CHJ, Allen AJ, Casat CHD, Ruff DD, Moore RJ, et al. Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential Response. Am J Psychiatry 2008;165:721-730. PMID:
18281409.
32. Clatworthy PL, Lewis SJ, Brichard L, Hong YT, Izquierdo D, Clark L, et al. Dopamine Release in dissociable striatal subregions predicts the different effects of oral methylphenidate on reversal learning and spatial working memory. J Neurosci 2009;29:4690-4696. PMID:
19369539.
33. Goldman-Rakic PS, Cools AR, Srivastava K. The prefrontal landscape: implications of functional architecture for understanding human mentation and the central executive [and discussion]. Phil Trans R Soc Lond B 1996;351:1445-1453. PMID:
8941956.
34. Gusstafson P, Svedin CG, Ericsson I, Lindén CH, Karlsson M, Therlnlund G. Reliability and validity of the assessment of neurological soft-signs in children with and without attention-deficit-hyperactivity disorder. Dev Med Child Neurol 2010;52:364-370. PMID:
19694777.